| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 10/04/2001 | CA2404496A1 Calcium binding regulatory subunit |
| 10/04/2001 | CA2404461A1 Human g-protein coupled receptors |
| 10/04/2001 | CA2404445A1 Tricyclic protein kinase inhibitors |
| 10/04/2001 | CA2404411A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 10/04/2001 | CA2404329A1 Treatment of cerebrovascular disease |
| 10/04/2001 | CA2404231A1 Methods of treating diseases with activated protein c |
| 10/04/2001 | CA2404157A1 Inhibition of a novel calcium injury current that forms in neurons during injury prevents neuronal cell death |
| 10/04/2001 | CA2403906A1 Pharmaceutical compositions containing oligosaccharides and preparation thereof |
| 10/04/2001 | CA2403857A1 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 10/04/2001 | CA2403800A1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 10/04/2001 | CA2403787A1 Il-8 receptor antagonists |
| 10/04/2001 | CA2403555A1 Methods for effecting neuroprotection |
| 10/04/2001 | CA2403515A1 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
| 10/04/2001 | CA2402735A1 Human transcription factors |
| 10/04/2001 | CA2402472A1 2,3,4,5-tetrahydro-1h-¬1,4|diazepino¬1,7a|indole compounds |
| 10/04/2001 | CA2402187A1 Intracorporeal medicaments comprising halogenated xanthene for photodynamic treatment of disease |
| 10/04/2001 | CA2401748A1 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders |
| 10/04/2001 | CA2401242A1 Pharmaceutically active pyrrolidine derivatives |
| 10/04/2001 | CA2399864A1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases |
| 10/04/2001 | CA2374911A1 G-protein coupled receptors |
| 10/03/2001 | CN1315945A Nitrate salts of antihypertensive medicines |
| 10/03/2001 | CN1315942A 2-oxo-j(2H)-quinoline derivatives |
| 10/03/2001 | CN1315863A Use of rosmarinic acid and derivatives thereof as immunosuppressant or inhibitor of SHz-mediated process |
| 10/03/2001 | CN1315856A Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 10/03/2001 | CN1315854A Microparticles |
| 10/03/2001 | CN1315853A Bioenhanced formulations comprising eprosartan in oral dosage form |
| 10/03/2001 | CN1315835A Antioxidant composition comprising acetyl L-carnitine and alpha-lipoic acid |
| 10/03/2001 | CN1315208A 166 HO-DTPA, its preparing method and application as liquid radiation source |
| 10/03/2001 | CN1315196A Antihypertensive medicine |
| 10/03/2001 | CN1072220C 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derives as neurokinin receptor antagonists |
| 10/03/2001 | CN1072209C Benzonitriles and benzofluorides |
| 10/03/2001 | CN1072017C Nutritive health food and preparing process thereof |
| 10/02/2001 | US6297399 Hypotensive agents |
| 10/02/2001 | US6297381 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor, ureas or thioureas substituted by a pyrrole or thiophene |
| 10/02/2001 | US6297375 4-phenyl-pyridine derivatives |
| 10/02/2001 | US6297359 Polypeptide for use in the treatment of diabetes, dietetics, hypertension and premature atherosclerosis |
| 10/02/2001 | US6297287 Substituted trialkylenetetramines or n,n'-bis(pyridinylalkyl)alkylenediamines |
| 10/02/2001 | US6297281 Association of no syntase inhibitors with trappers of oxygen reactive forms |
| 10/02/2001 | US6297277 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 10/02/2001 | US6297269 Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors |
| 10/02/2001 | US6297267 Prostaglandin i2 agonist. |
| 10/02/2001 | US6297266 Inhibit the binding of adhesive proteins to the surface of different types of cell and accordingly influence cell-cell and cell-matrix interactions. |
| 10/02/2001 | US6297265 Benzoisothiazole-substituted compounds useful as IL-8 receptor antagonists |
| 10/02/2001 | US6297261 Potent chloride channel blockers; treatment of sickle cell anemia, brain edema following ischaemia or tumors, diarrhea, hypertension (diuretic), osteoporosis, and for the reduction of the intraocular pressure |
| 10/02/2001 | US6297260 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 10/02/2001 | US6297241 Treatment of disorders which are responsive to the opening of the large conductance calcium-activated potassium channels. |
| 10/02/2001 | US6297239 Inhibitors of prenyl-protein transferase |
| 10/02/2001 | US6297238 3-aryl pyrazoles with 4,5(3,4)-bicyclic ring fusion which are inhibitors of protein kinases particularly tyrosine kinases and serine/threonine kinases |
| 10/02/2001 | US6297233 Lactam inhibitors of FXa and method |
| 10/02/2001 | US6297232 Triazolo[4,5-D]pyrimidinyl derivatives and their use as medicaments |
| 10/02/2001 | US6297226 Treating a disease or a condition in a mammal treatable by inhibiting the activity of a monoamine oxidase |
| 10/02/2001 | US6297221 Method for promoting angiogenesis with a nucleic acid construct comprising an SM22α0 promoter |
| 10/02/2001 | US6297220 Recombinant adenovirus comprising a dna sequence that codes for a gene product is delivered to a cardiac or vascular smooth muscle cell and the cell is maintained until that gene product is expressed. |
| 10/02/2001 | US6297218 Phospholipid complexes prepared from extracts of Vitis vinifera as anti-atherosclerotic agents |
| 10/02/2001 | US6297036 YAK-1 related serine/threonine protein kinase-HTLAR33 |
| 10/02/2001 | US6297022 Method of identifying agonists and antagonists for tumor necrosis related receptor TR1 |
| 10/02/2001 | US6296878 Anti-inflammatory and anti-itching action, prevention and/or treatment of disorders of cardiovascular system, protective action against ultraviolet radiation, analgesic, promotive action on proliferation of fibroblasts, therapy of fire burn |
| 09/27/2001 | WO2001071358A1 Method of screening for inhibitors of osteopontin |
| 09/27/2001 | WO2001071004A2 Proteases |
| 09/27/2001 | WO2001070984A2 Anti-tissue factor antibodies with enhanced anticoagulant potency |
| 09/27/2001 | WO2001070978A2 Polypeptides and nucleic acids encoding same |
| 09/27/2001 | WO2001070974A1 Novel protein, process for producing the same and use thereof |
| 09/27/2001 | WO2001070953A2 Identification of modulators of the inteferon gamma signaling pathway and their use in restenosis treatment |
| 09/27/2001 | WO2001070952A1 Human gata-5 transcription factor |
| 09/27/2001 | WO2001070945A1 Recombinant proteins containing shiga-like toxin and vascular endothelial growth factor fragments |
| 09/27/2001 | WO2001070808A2 Angiogenesis - associated proteins, and nucleic acids encoding the same |
| 09/27/2001 | WO2001070807A2 G-protein associated molecules |
| 09/27/2001 | WO2001070798A2 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 09/27/2001 | WO2001070775A2 Wnt-1 related polypeptides, and nucleic acids encoding the same |
| 09/27/2001 | WO2001070771A2 Acute neuronal induced calcium binding protein type 1 ligand |
| 09/27/2001 | WO2001070769A1 Peptide derivative |
| 09/27/2001 | WO2001070757A2 Thioketals and thioethers for inhibiting the expression of vcam-1 |
| 09/27/2001 | WO2001070754A1 Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors |
| 09/27/2001 | WO2001070753A1 Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors |
| 09/27/2001 | WO2001070748A1 THIEPINO [3,2-b] DIHYDROPYRIDINES AND RELATED COMPOSITIONS AND METHODS |
| 09/27/2001 | WO2001070741A1 5-alkylpyrido[2,3-d]pyrimidines tyrosine kinase inhibitors |
| 09/27/2001 | WO2001070738A2 Tri-aryl-substituted-ethane pde4 inhibitors |
| 09/27/2001 | WO2001070734A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 09/27/2001 | WO2001070733A2 Di-substituted iminoheterocyclic compounds |
| 09/27/2001 | WO2001070732A1 Pyrazoline derivatives or tetrahydropyridazine derivatives and medicinal use thereof |
| 09/27/2001 | WO2001070729A1 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors |
| 09/27/2001 | WO2001070723A1 Benzothiophene derivatives and medicinal use thereof |
| 09/27/2001 | WO2001070716A1 A process for the preparation of epothilone analogs and intermediates |
| 09/27/2001 | WO2001070709A2 3-oxy-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadazine-1,1-dioxide derivatives having diuretic and/or natriuretic activity |
| 09/27/2001 | WO2001070700A1 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 09/27/2001 | WO2001070698A1 Quinoline derivatives and medicinal use thereof |
| 09/27/2001 | WO2001070695A1 Pyridine derivatives as inhibitors of p38 |
| 09/27/2001 | WO2001070694A1 Amorphous torasemide modification |
| 09/27/2001 | WO2001070693A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |
| 09/27/2001 | WO2001070690A1 Heterocyclic side chain containing metalloprotease inhibitors |
| 09/27/2001 | WO2001070683A2 3-substituted-4-pyrimidone derivatives |
| 09/27/2001 | WO2001070674A1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 09/27/2001 | WO2001070673A2 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a) |
| 09/27/2001 | WO2001070668A2 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 09/27/2001 | WO2001070662A2 2,4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 09/27/2001 | WO2001070591A1 Infusion packet with useful and decorative elements, support member, delivery system and method |
| 09/27/2001 | WO2001070273A1 The use of anticoagulant agents in the extracorporeal treatment of blood |
| 09/27/2001 | WO2001070266A2 Method of inhibiting stenosis and restenosis with a mixture of antibodies anti cd18 and anti ccr2 |
| 09/27/2001 | WO2001070260A1 Cd18-binding antibodies inhibit stenosis-related disorders |
| 09/27/2001 | WO2001070248A1 Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress |